Earnings Outlook For Arcutis Biotherapeutics
Portfolio Pulse from Benzinga Insights
Arcutis Biotherapeutics (NASDAQ:ARQT) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.86. The company's past performance shows a pattern of share price drops following earnings reports, with shares currently trading at $2.26 and down 87.79% over the last 52-week period.
November 02, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Arcutis Biotherapeutics is expected to report an EPS of $-0.86. Given the company's history of share price drops following earnings reports and the overall negative returns, the upcoming earnings release could potentially impact the stock negatively.
Arcutis Biotherapeutics has a history of share price drops following earnings reports. Given the analysts' estimate of a negative EPS and the overall negative returns over the past year, it is likely that the upcoming earnings release could further depress the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100